Organizational Change Management Lead
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
Our Values
Trust: We build and maintain trust in all our relationships – both with each other and with our customers. We support each other and work as a team.
Innovation: We are curious and driven by finding smart solutions to the challenges we face.
Excellence: We always strive to deliver high quality and adapt to meet the needs of our customers.
About the Role
As part of the global ERP Program Team, the Organizational Change Management (OCM) Lead plays a key role in driving the successful adoption of SAP S/4HANA across PolyPeptide’s global manufacturing organization.
This role is central to ensuring that new ERP processes are successfully embedded across production sites, supply chain, finance, and quality functions in a highly regulated pharmaceutical manufacturing environment.
You will work closely with the Program Director, PMO, deployment leads, and global process owners to translate ERP design decisions into practical operational impact for the business.
The position requires a hands-on and pragmatic change leader who can combine strategic thinking with practical execution across the full transformation lifecycle – from design and impact assessments to training, go-live readiness, and adoption tracking.
Key Responsibilities
Execution of the program’s OCM strategy supporting the global SAP S/4HANA transformation.
Lead change impact assessments across production, supply chain, finance, and quality functions.
Translate ERP design decisions into clear operational implications for manufacturing sites.
Plan and execute communication, stakeholder engagement, and training strategies.
Drive business readiness and user adoption across multiple program rollout waves.
Establish and track adoption and readiness KPIs.
Partner closely with PMO, deployment leads, and global process owners.
Build and manage a global network of change agents and super users.
Enable local leaders and site management to lead the transformation successfully.
Important stakeholders
Global Process Owners
Super Users
People Managers
C-executives
Program team
Your Profile
To succeed in this role, you bring experience from ERP transformation programs and organizational change management in production-driven environments.
We expect that you have:
5+ years of experience within Organizational Change Management in large digital or ERP transformation programs.
Proven experience supporting SAP or ERP implementations, preferably SAP S/4HANA.
Experience working with global rollout programs including design, testing, readiness, cutover, and hypercare.
Solid experience conducting change impact assessments, stakeholder engagement, communication planning, and training strategies.
Experience working in manufacturing environments, ideally within pharma, life sciences, chemical production, or other regulated industries.
Ability to translate ERP design decisions into practical implications for operational teams.
Strong stakeholder management skills and the ability to work with both senior leadership and operational teams.
Fluent verbal and written English.
French language skills are considered a strong advantage, as the role involves collaboration with several of PolyPeptide’s European sites.
Experience with SAP Activate or other structured ERP methodologies is an advantage.
You are a pragmatic and grounded change leader who can operate effectively in complex transformation programs.
You are comfortable working hands-on with change activities, while also providing strategic guidance to program leadership.
You communicate clearly and practically, especially with production and operational stakeholders, and you are able to translate complex ERP concepts into business-relevant language.
Travel
As this is a global ERP transformation program, the role will involve regular travel to PolyPeptide sites in Europe and the US to support rollout activities, stakeholder engagement, and change initiatives.
FIND THIS INTERESTING? APPLY NOW!
Are you ready to take the next step in your career? The position will be open until March 29th 2026, but we are applying an ongoing selection so do not hesitate to send us your application.
Our ERP team is primarily based in Malmö, Sweden, but we also welcome applicants located near our sites in:
Braine, Belgium
Strasbourg, France
provided you are within commuting distance of one of these locations.
For more information, please contact Simon Schlamovitz at Simon.Schlamovitz@polypeptide.com. Swedish applicants are welcome to contact the local union chairman for Akademikerföreningen or Unionen at +46 040-36 62 00 for support.
- Locations
- Malmö, Strasbourg, Braine-l'Alleud
- Remote status
- Hybrid
Our Core Values
INNOVATION
- We are curious and explore new ways.
- We are also ambitious and find solutions.
EXCELLENCE
- We have a strong technical knowledge, and we deliver results
- We lead quality in everything we do
- We are adaptable and customer focused
TRUST
- We believe in teamwork and collaboration.
- We lead by example and accept responsibility
- We are transparent and we show integrity.
About PolyPeptide Group
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.